Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Apitoria Pharma Private Limited | Sangareddy, India | Makes the active ingredient and tests it | Problems found, fixed voluntarilySep 27, 2024 · 6 inspections |
| Eugia Pharma Specialities Limited | Sangareddy, India | Makes it, tests it and packages it | Serious problems, FDA actionFeb 6, 2026 · 7 inspections, 2 with FDA action |
Recalls
- Jan 14, 2022 · Class II · Aurobindo Pharma USA Inc.
Failed Impurities/Degradation Specifications
Lots: Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023 - Dec 2, 2019 · Class III · AuroMedics Pharma LLC
Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Lots: Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Moxifloxacin: every company that makes it
- Form
- solution/ drops, ophthalmic
- Strength
- 5 mg per 1 mL
- Approval
- ANDA ANDA206242
- On the market since
- Oct 4, 2017
- Package NDCs
65862-840-03- Official label
- DailyMed (National Library of Medicine), updated Sep 18, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?